Posts
Welcome to a world of limitless possibilities, where the journey is as exhilarating as the destination, and where every moment is an opportunity to make your mark.
-
An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of “magic mushrooms.” A veteran conquers his post-traumatic stress disorder through therapy using MDMA, a synthetic compound known on the street as “ecstasy” or “molly.” A stay-at-home mom tries LSD, otherwise known as acid, for her anxiety. Nearly…
-
The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders. Delivered in collaboration with the University of Exeter and Devon Partnership NHS Trust, the studies involve using regulated forms of psychedelic drugs. These innovative therapies could prove effective for treating conditions such…
-
Last summer’s FDA rejection of Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder was a demoralizing blow for the psychedelics space but the sector is seeing a resurgence in 2025 with promising new data, an adjacent approval and a possible assist from newly confirmed HHS Secretary Robert F. Kennedy Jr. Last month, Johnson & Johnson’s…
Psilosofia 